ALA-5000, a sustained release injectable for Schizophrenia
Category: Pharmaceutical
Exhibitor: ALAR PHARMACEUTICALS INC.
Booth No: M636
Characteristic
ALA-5000 is a long-acting injection for treating Schizophrenia using Alar self-developed In-Relar sustained release drug delivery platform. Through steadily releasing therapeutic levels of third generation antipsychotic drug without dose dumping, ALA-5000 is anticipated to reduce the burden of drug administration, improving patients' medication adherence and convenience.
Other Products
Products you may be interested in
Highest Rated Products